This inventor holds 1 USPTO granted patent. Top assignee: Bio-Thera Solutions, Ltd.. Active years: 2021.
Company Filing History:
Years Active: 2021
Title: Xian Peng: Innovator in TROP2 Targeted Therapies
Introduction
Xian Peng is a notable inventor based in Science, China. He has made significant contributions to the field of medical research, particularly in the development of therapies targeting TROP2 positive diseases. His innovative work has the potential to impact the treatment of various malignancies.
Latest Patents
Xian Peng holds 1 patent for his invention titled "Compounds and methods for the treatment of TROP2 positive diseases." This patent encompasses compounds that include antibodies, antigen-binding fragments, polypeptides, and immunoconjugates that specifically bind to TROP2 (TACSTD2). The invention also outlines methods for utilizing these TROP2-binding molecules in diagnosing and treating diseases, particularly malignancies.
Career Highlights
Xian Peng is currently associated with Bio-Thera Solutions, Ltd., where he continues to advance his research and development efforts. His work at the company focuses on innovative therapeutic solutions that address critical health challenges.
Collaborations
Xian collaborates with esteemed colleagues, including Weijia Tang and Xiaoyang Huang, who contribute to his research endeavors and help drive forward the mission of developing effective treatments.
Conclusion
Xian Peng's contributions to the field of medical innovation, particularly in TROP2 targeted therapies, highlight his role as a key inventor in advancing healthcare solutions. His work promises to enhance the diagnosis and treatment of serious diseases, showcasing the importance of innovation in medicine.